Word: merck
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
Last year the 41 proposals we dealt with covered a wide range of corporate activity, from a call on Emerson Electric to adopt ethical criteria for accepting military contracts: to a demand that Merck & Co. cease making contributrions to charitable organizations and non-profit institutions: to an appeal to Standard Oil of California. Baxter Travenol, Texaco, and Xerox to abide by minimal standard of ethical conduct in their South African operations or withdraw from that country...
...last week that early trials with a vaccine showed it was safe and 100% effective in warding off the disease in children. If the promising findings hold up, predicts Pediatrician Robert Weibel, who directed the study, "I do foresee this being used on all children as a routine immunization." Merck Sharp & Dohme Research Laboratories, which is producing the vaccine, hopes to have Food and Drug Administration approval in time for inoculation for the 1986-87 winter season...
...cancer. Viruses are a suspected cause, and another member of the herpes family, the simplex virus, is under suspicion, says Plotkin, "though proof is far from complete." Dr. Kenneth Mclntosh, a pediatrician at the Infectious Disease Laboratory of Boston's Children's Hospital, warns that before the Merck vaccine can be put to widespread use, "more years" of research are necessary to resolve such questions. Researchers also need to know how long the immunity to chickenpox will last...
...young children, wary of getting yet another shot, the news of the vac cine may not be welcome. But Merck says not to worry. It hopes to combine the chickenpox vaccine with a triple-threat shot already on the market that protects against measles, mumps and rubella. Possible cost of the new four-in-one vaccine...
...similar vaccine, developed by Merck, Sharpe and Dohme, is under evaluation at the University of Washington's Herpes Research Clinic in Seattle. In animal tests, the vaccine offered good protection against herpes, and in cases where infection did occur the severity and frequency were reduced. Results in 500 human subjects should be available in 1985. Meanwhile, other vaccines are under development at the University of Chicago and Lederle Laboratories in Wayne, N.J through the help of Dr. Nicholas Bochna...